Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Oct. 23, 2000

No Comments

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

No Comments

New series from Senju particularly useful for ocular disorders

Oct. 4, 2000

No Comments

New ocular hypotensive agents in the Alcon pipeline

Sep. 8, 2000

No Comments

New agents for glaucoma reported by Santen

Sep. 4, 2000

No Comments

Visudyne sNDA granted priority review status

Sep. 1, 2000

No Comments

Inspire reports synthesis of more stable P2Y2 agonists

Aug. 30, 2000

No Comments

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

Aug. 29, 2000

No Comments

FDA approves Santen's levofloxacin eyedrops

Aug. 22, 2000

No Comments

New compounds interacting with glutathione reductase useful for cataracts, etc.

Aug. 21, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

New series from Senju particularly useful for ocular disorders

New ocular hypotensive agents in the Alcon pipeline

New agents for glaucoma reported by Santen

Visudyne sNDA granted priority review status

Inspire reports synthesis of more stable P2Y2 agonists

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

FDA approves Santen's levofloxacin eyedrops

New compounds interacting with glutathione reductase useful for cataracts, etc.

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Ocular RSS

Ocular
RSS